Navigation Links
Teething Problems of Sinuplasty

Sinusitis is a condition in which the sinuses become inflamed or infected affecting 37 million people. Previously the only hope was a conventional surgery//. But now Acclarent has come up with a new procedure called balloon sinuplasty which involves inflating a small balloon in the sinus cavity which clears the blocked sinus. It is considered as a major breakthrough that offers hope to many sinusitis sufferers. It cost thousands of dollars and has been performed on about 500 patients since November 2004.

But the procedure has not been scientifically proved and is not approved by the FDA. Only two studies have been conducted one involving 6 cadavers and the other on only 10 patients. In the second about 8 patients had previously undergone the traditional sinus surgery. This makes it difficult to determine whether the system, made by Acclarent has helped the patients. The procedure’s lasting effect is also being questioned.

On the other hand leading sinus specialists said that balloon sinuplasty is being adopted more on the basis of astute marketing than clinical science. Acclarent has received $42.5 million in venture capital financing and is based in Menlo Park, Calif., has trained about 150 doctors in balloon sinuplasty. The company has also been successful in finding several high-profile specialists to serve as company consultants.

The company's Web site said that clinical studies had shown the treatment to be "safe and effective. It also said that the same technology is being pursued by surgeons to open coronary arteries. The Acclarent's system requires the use of radiation to enable doctors to see where to place the balloon. Patients are eager because of the lack of trauma compared with standard surgery, which typically involves more pain and bleeding. The surgery is also being covered by insurance.

But sinus specialists say the true test for sinuplasty is whether it will prove to be effective over the long term at keepin g the sinuses open. Dr. Friedman, a professor at Rush University Medical Center and chairman of otolaryngology at Advocate Illinois Masonic Medical Center, is conducting a study of 90 patients, who will be followed for a year, to compare how they fare if they are treated with drugs only, with traditional surgery or with sinuplasty.

Sinus specialists who want training beyond a simple introduction to the technology must make an upfront commitment to buy $20,000 worth of Acclarent's equipment, including the catheters and balloons involved. Each system, which is disposed after a single use, costs about $1,200. In conclusion it is said that this new procedure is said to be effective only if it is effective for a longer period.


'"/>




Related medicine news :

1. Parents Warned About Contaminated Teething Rings By FDA
2. Teething Problems – Fight Sugar For Children’s Dental Healh
3. Low Birth Weight infants could have Problems in the Future
4. Oxygen Usage During Exercise Could Indicate Heart Problems
5. Hormones A Predictor Of Heart Problems
6. Stress can Trigger Heart Problems
7. Problems Of a Growing Company
8. A Drug Used To Treat Heat Problems May Benefit Stroke Patients
9. Problems Associated With Iron Deficiency
10. The Cause Of Visual Problems Different From Race To Race
11. Biochemical Markers Might Help Predict Heart Problems
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... ... July 24, 2017 , ... ... that already work hand-in-hand on an Innovation Collaboration program, have signed a five-year ... experience and cost of the care members and patients receive. The agreement also ...
(Date:7/24/2017)... California (PRWEB) , ... July 24, 2017 , ... ... of autologous fat (adipose) transfer systems announces the issuance of United States Patent ... patent) for its adipose filtration technology. The '398 and '324 patents cover ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... August 13-17 in National Harbor, MD. This year's theme focuses on the new ... principal benchmarks for quality and integrity in testing and calibration will be changed. ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... sleep management solution focused on delivering end-to-end sleep health care at ... , Recent literature shows that adherence rates for positive airway pressure (PAP) therapy, ...
(Date:7/24/2017)... ... July 24, 2017 , ... A Southern California-based author has ... sexual abuse, and how she has overcome them. “Forbidden Memories: A Memoir,” by author ... and how she has risen above. , In “Memories,” readers get a firsthand look ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)...  The global market for liquid biopsy diagnostic and ... in 2016.  Although in early stages, the global market ... as a result of the gradual shift towards personalized ... of a significant number of new liquid biopsy tests ... biomarkers to guide treatment decisions. ...
(Date:7/10/2017)... CLEVELAND , July 10, 2017  US medical ... billion in 2021, according to Medical Equipment ... released by Freedonia Focus Reports. Continued increases in demand ... the aging of the population and supported by gains ... associated equipment and supplies. New product introductions will also ...
(Date:7/10/2017)... PARK, N.C. , July 10, 2017 ... $5m Convertible Note to support the development of CRISPR-Cas3 ... Tencent Holdings Limited, a leading Chinese Internet services provider, ... funding will advance multiple infectious disease product programs targeting ... Founded by Dr. Rodolphe ...
Breaking Medicine Technology: